These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Significance of cone biopsy margins in the management of patients with cervical neoplasia. Lubicz S, Ezekweche C, Allen A, Schiffer M. J Reprod Med; 1984 Mar; 29(3):179-84. PubMed ID: 6726696 [Abstract] [Full Text] [Related]
3. Cervical cone margins as a predictor for residual dysplasia in post-cone hysterectomy specimens. Phelps JY, Ward JA, Szigeti J, Bowland CH, Mayer AR. Obstet Gynecol; 1994 Jul; 84(1):128-30. PubMed ID: 8008307 [Abstract] [Full Text] [Related]
8. [Histological examination of the surgical specimen after hysterectomy in patients previously conized for intraepithelial neoplastic lesions of the cervix uteri. The problem of cytological recurrence and the incomplete cone]. Marchionni M, Ottaviano M, Battaglia GB, Campatelli C. Minerva Ginecol; 1976 Nov; 28(11):903-6. PubMed ID: 1012582 [No Abstract] [Full Text] [Related]
9. [Cervical conization in dysplasia and carcinoma in situ. Role of concomitant uterine curettage]. Kazadi Buanga J, Acosta Vazquez MJ. Rev Fr Gynecol Obstet; 1994 Dec; 89(12):602-5. PubMed ID: 7846467 [Abstract] [Full Text] [Related]
10. Management of patients with positive margins after cervical conization. Lapaquette TK, Dinh TV, Hannigan EV, Doherty MG, Yandell RB, Buchanan VS. Obstet Gynecol; 1993 Sep; 82(3):440-3. PubMed ID: 8355949 [Abstract] [Full Text] [Related]
11. Prediction of residual neoplasia based on histopathology and margin status of conization specimens. Chang DY, Cheng WF, Torng PL, Chen RJ, Huang SC. Gynecol Oncol; 1996 Oct; 63(1):53-6. PubMed ID: 8898168 [Abstract] [Full Text] [Related]
12. The presence of residual disease in the cervix of hysterectomy specimens from women in whom there has been a previous diagnosis of cervical carcinoma. Heatley MK. J Obstet Gynaecol; 2002 Jan; 22(1):45-7. PubMed ID: 12521728 [Abstract] [Full Text] [Related]
14. Adenocarcinoma in situ of the cervix: management and outcome. Azodi M, Chambers SK, Rutherford TJ, Kohorn EI, Schwartz PE, Chambers JT. Gynecol Oncol; 1999 Jun; 73(3):348-53. PubMed ID: 10366458 [Abstract] [Full Text] [Related]
15. [Mild cervix dysplasia: does diagnostic biopsy have a "therapeutic" effect?]. Kainz C, Gitsch G, Reinthaller A, Tatra G, Breitenecker G. Gynakol Rundsch; 1991 Jun; 31 Suppl 2():223-5. PubMed ID: 1665136 [No Abstract] [Full Text] [Related]
16. Cone biopsy and hysterectomy in the management of cervical intraepithelial neoplasia. Jones HW. Baillieres Clin Obstet Gynaecol; 1995 Mar; 9(1):221-36. PubMed ID: 7600728 [No Abstract] [Full Text] [Related]
17. Endocervical gland involvement by cervical intraepithelial neoplasia grade III. Predictive value for residual and/or recurrent disease. Demopoulos RI, Horowitz LF, Vamvakas EC. Cancer; 1991 Nov 01; 68(9):1932-6. PubMed ID: 1913543 [Abstract] [Full Text] [Related]
18. Evaluating cervical cone biopsy specimens with frozen sections at hysterectomy. Neiger R, Bailey SA, Wall AM, Jennings JB, Gallup DG. J Reprod Med; 1991 Feb 01; 36(2):103-7. PubMed ID: 2010890 [Abstract] [Full Text] [Related]
20. Is it the severity of dysplasia or is it the presence or absence of dysplasia in cone biopsy specimens that predicts residual dysplasia in hysterectomy? Mittal K. Am J Obstet Gynecol; 1996 Mar 01; 174(3):1079-80. PubMed ID: 8633643 [No Abstract] [Full Text] [Related] Page: [Next] [New Search]